Macleod 2014 Lancet

From Bioblast
Revision as of 13:07, 20 November 2020 by Iglesias-Gonzalez Javier (talk | contribs) (Created page with "{{Publication |title=Macleod MR, Michie S, Roberts I, Dirnagl U, Chalmers I, Ioanidis JPA, Salman RAS, Chan AW, Glasziou P (2014) Biomedicel research: increasing value, reduc...")
(diff) ← Older revision | Latest revision (diff) | Newer revision β†’ (diff)
Publications in the MiPMap
Macleod MR, Michie S, Roberts I, Dirnagl U, Chalmers I, Ioanidis JPA, Salman RAS, Chan AW, Glasziou P (2014) Biomedicel research: increasing value, reducing waste.. Lancet 383(9912):101-4.

Β» PMID: 24411643

Macleod MR, Michie S, Roberts I, Dirnagl U, Chalmers I, Ioanidis JPA, Salman RAS, Chan AW, Glasziou P (2014) Lancet

Abstract: Of 1575 reports about cancer prognostic markers pub lished in 2005, 1509 (96%) detailed at least one signifi cant prognostic variable.1

However, few

identifi ed biomarkers have been confi rmed by subsequent research and few have entered routine clinical practice.2

This patternβ€”initially promising

fi ndings not leading to improvements in health careβ€”has been recorded across biomedical research. So why is research that might transform health care and reduce health problems not being successfully produced?

β€’ Bioblast editor: Iglesias-Gonzalez J


Labels:






Publication efficiency 

Cookies help us deliver our services. By using our services, you agree to our use of cookies.